Literature DB >> 2942423

Hemodynamic effects of atrial natriuretic hormone.

B L Pegram, N C Trippodo, T Natsume, M B Kardon, E D Frohlich, F E Cole, A A MacPhee.   

Abstract

The atrial natriuretic hormone (ANH) alters cardiovascular function independent of changes in body fluid volume. Most investigators agree that ANH decreases mean arterial pressure (MAP). However, although some investigators have observed a decrease in total peripheral resistance in association with the decrease in MAP, a more frequent observation has been decreased cardiac output (CO). The mechanism whereby ANH decreases CO is unknown, but does not appear to be the result of direct myocardial depression, reductions in intravascular or cardiopulmonary volumes, or venodilation. Alterations in skeletal muscle and splanchnic blood flow have been reported by some but not all investigators. Although increases in renal blood flow have been reported, they are transitory and have not been consistently observed by all researchers. The cardiovascular effects of ANH appear to be influenced not only by the dose, but also by the cardiovascular control mechanisms that operate at the time of ANH administration. Non-renin-dependent hypertensive models exhibit a decrease in MAP associated with decreased CO, whereas in renin-dependent animals this hypotension is associated with a decrease in total peripheral resistance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942423

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  4 in total

1.  Calcitonin gene-related peptide, neuropeptide Y and atrial natriuretic peptide distribution in guinea pig heart from paraffin wax-embedded and formalin-cryoprotected tissues.

Authors:  G N Onuoha; E K Alpar; D P Nicholls; K D Buchanan
Journal:  Histochem J       Date:  1999-09

2.  The effect of iron overload in the hearts of patients with beta-thalassemia.

Authors:  S V Brili; A I Tzonou; S S Castelanos; C J Aggeli; C A Tentolouris; C E Pitsavos; P K Toutouzas
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

3.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Vascular responses to local atrial natriuretic peptide infusion in man.

Authors:  D J Webb; N Benjamin; M J Allen; J Brown; M O'Flynn; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.